First, we focus on soluble dipeptidyl peptidase 4 (s-DPP4) and C–C motif chemokine 11 (CCL11) as biomarkers and potential therapeutics for post-stroke cognition that have been previously reported on in the context of stroke and in cognition. Here, CCL11 is linked to stroke disorder.